tiprankstipranks
Trending News
More News >
TriplePoint Venture Growth (TPVG)
NYSE:TPVG

TriplePoint Venture Growth (TPVG) AI Stock Analysis

Compare
789 Followers

Top Page

TPVG

TriplePoint Venture Growth

(NYSE:TPVG)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
$5.50
▲(4.76% Upside)
Action:ReiteratedDate:03/05/26
The score is held back primarily by inconsistent financial performance and cash-flow volatility, plus weak technicals with the stock trading below major moving averages. Offsetting factors include supportive earnings-call updates on liquidity/capital actions and origination momentum, and a very high dividend yield, though earnings-based valuation is unclear given the reported P/E of 0.0.
Positive Factors
Origination momentum & large pipeline
TriplePoint materially scaled originations in 2025 (>$508M commitments, $287M funded) with a >$2.0B pipeline. Sustained origination throughput increases interest and fee income potential, diversifies borrower exposure, and raises revenue visibility for multiple quarters if underwriting and funding execution continue.
Strengthened liquidity & liability profile
Management extended and increased near-term liquidity, refinanced maturing notes and issued new senior notes while keeping revolver capacity. These actions lengthen maturities, reduce immediate refinancing risk and leave leverage at manageable levels, improving solvency and strategic flexibility over the next several quarters.
Sponsor alignment & adviser fee relief
Sponsor share purchases and an extended adviser fee waiver materially align incentives and reduce operating drag. Fee relief increased reported net investment income and improves distributable earnings durability, while sponsor stock buying signals commitment that can stabilize capital support during portfolio realizations.
Negative Factors
Portfolio yield compression
A 200bp decline in portfolio yield in one year reduces net interest margins and long-term earning power absent offsetting cost reductions or higher volumes. As yields moderate because of mix shifts and lower base rates, durable earnings per dollar invested will be lower and require sustained origination growth to offset margin erosion.
Cash-flow & profitability volatility
Inconsistent operating and free cash flows—large positive flows in 2023–24 followed by a sharp negative in 2025—and erratic profit history undermine the predictability of distributions and reinvestment. This variability stems from timing of realizations, prepayments and credit outcomes, making capital planning and dividend coverage less durable.
Credit workouts & equity/warrant realization risk
Active credit restructurings and recoveries (e.g., Frubana, NA‑KD) create uncertainty over timing and magnitude of recoveries and can lock value in equity or illiquid instruments. Such workouts and unrealized equity/warrant exposures increase NAV volatility and delay cash realizations, constraining durable upside from equity-linked positions.

TriplePoint Venture Growth (TPVG) vs. SPDR S&P 500 ETF (SPY)

TriplePoint Venture Growth Business Overview & Revenue Model

Company DescriptionTriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
How the Company Makes MoneyTPVG generates revenue primarily through interest income from its debt investments and financing solutions provided to venture growth stage companies. The company earns money by charging interest on the loans and credit facilities it provides, as well as through origination and other fees associated with its financing activities. TPVG's earnings are also influenced by its ability to maintain strong relationships with venture capital firms, which often refer high-quality investment opportunities, and by managing the credit risk of its portfolio effectively.

TriplePoint Venture Growth Earnings Call Summary

Earnings Call Date:Mar 04, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 06, 2026
Earnings Call Sentiment Positive
The call highlighted meaningful progress in originations, portfolio growth, NAV improvement, liquidity and capital structure actions, along with active sponsor alignment and incentives that materially support earnings and flexibility. Offsetting items include yield compression amid a lower-rate environment, volatility and unrealized losses in the warrant/equity portfolio, specific credit workouts (NA-KD, Frubana, Prodigy), and near-term exit-market uncertainty. Overall, the company is positioned with stronger origination momentum, a larger pipeline and improved balance-sheet flexibility, though execution risks remain tied to credit resolutions and public/exit market timing.
Q4-2025 Updates
Positive Updates
Strong Origination and Funding Growth
Closed $508M of new debt commitments in 2025 versus $175M in 2024 (≈+190%), and funded $287M during 2025 versus $135M in 2024 (≈+113%), marking the highest origination activity in over two years. Adviser/TriplePoint signed $1.2B of term sheets in 2025 (≈+63% vs $736M in 2024). Pipeline exceeded $2.0B at year-end.
Portfolio Size and NAV Improvement
Total investment portfolio at fair value grew to ~$784M from $676M at 12/31/24 (+16% YoY). Net asset value increased to $8.73 per share from $8.61 (+$0.12, ≈+1.4% YoY). Net increase in net assets from operations was $49.2M ($1.22/share) in 2025 versus $32.0M ($0.82/share) in 2024 (≈+54%).
Increased Diversification and New Borrowers
Added 28 new borrowers in 2025 (an increase of 250% over the prior year) and expanded sector/geographic diversification, including AI-native and strategic sectors (aerospace, defense, advanced manufacturing). Two-thirds of Q4 commitments were to new portfolio companies.
Improved Fundraising and Equity/Warrant Positions
Warrant and equity positions rose to a total fair value of $138M from $116M a year ago (≈+19%), with warrants in 118 companies and equity in 55. Several portfolio companies are positioned as top IPO/M&A candidates (e.g., Cohesity, Revolut, Dialpad, GrubMarket).
Liquidity and Capital Structure Strengthening
Total liquidity of $252.4M (cash $47.4M + $205M available revolver). Revolving credit facility extended (revolver period to Nov 30, 2027; maturity to May 30, 2029). Issued $75M senior notes at 7.5% to help repay $200M maturing notes; gross leverage 1.33x, net leverage 1.20x.
Sponsor Alignment and Expense Relief
Sponsor/TPC purchased ~1.8–2.0M shares (~nearly 5% of outstanding shares), and the adviser waived income incentive fees (~$5.3M waived in 2025) and extended the waiver through 2026, increasing reported net investment income by ~$8.5M for FY2025.
Earnings and Distributions
Generated net investment income of $42.3M ($1.05/share) for FY2025 on total investment and other income of $90.9M. Declared and paid total distributions of $1.08 per share (regular $1.06 + supplemental $0.02). Estimated spillover income of $42.3M ($1.04/share) heading into 2026.
Recovery and Realizations
Recognized $4.8M of net realized gains in Q4 related to a restructuring, and saw recoveries/resolutions (e.g., full recovery from 30 Madison / Pill Club transaction). Restructuring of NA-KD converted part of debt to hybrid/equity, producing recognized gains versus cost basis.
Negative Updates
Declining Portfolio Yields
Weighted average annualized portfolio yield on debt investments fell to 13.7% for FY2025 from 15.7% in FY2024 (down 2.0 percentage points). Q4 yield was 12.7%; onboarding yields moderated due to lower base rates, mix shift toward higher-quality borrowers, revolving loans and lower OID.
Warrant/Equity Volatility and Unrealized Losses
Q4 experienced net unrealized losses of $11.6M on the warrant/equity portfolio, producing an overall Q4 unrealized loss of $6.6M (offset partially by debt fair value gains). This drove quarter-to-quarter NAV volatility despite YoY NAV improvement.
Credit Watch and Specific Credit Challenges
One Category 5 (Red) obligor, Frubana, remains in recovery (25% recoveries in Q4). Prodigy Finance saw fair value reductions due to business/sector performance. NA-KD required lender recap/restructuring and conversion to equity, reflecting a credit workout vs. normal repayment.
Reduced Prepayments Versus Prior Year and Cash Reinvestment Dynamics
Total loan prepayments were $120M in 2025 versus $170M in 2024 (lower liquidity from prepays vs prior year), though 2025 still benefited from $212M of scheduled principal, prepayments and early repayments overall. Management noted reinvestment targets of $25M–$50M per quarter in 2026 absent higher prepayment visibility.
Exit Market Uncertainty
Management highlighted IPO market delays and near-term volatility (AI-driven market reactions) that may postpone IPO-driven exits; M&A activity is improving but valuations/multiples remain to be proven, adding uncertainty to realization timelines for warrants/equity.
Concentrated Near-Term Maturity Profile & Cost of Capital
Recent refinancings resulted in certain maturities concentrated in late 2027/early 2028, which management is monitoring. The company also acknowledged relatively high cost of capital and a small market capitalization that has depressed trading levels below book value.
Quarterly Income Slightly Weakened
Net investment income in Q4 was $9.9M ($0.25/share) versus $10.3M ($0.26/share) in the prior quarter, reflecting the rate environment and yield compression.
Company Guidance
Management guided 2026 with a quarterly new‑funding target of $25–$50 million (unless prepayments provide visibility), noting $155 million of new term sheets and $15 million of funding so far in Q1 and a pipeline exceeding $2.0 billion; they emphasized strong liquidity and a refined capital profile with $252.4 million total liquidity ($47.4m cash + $205m revolver capacity), an extended revolver to 11/30/2027 (final maturity 5/30/2029), issuance of $75 million of 7.5% senior notes due Feb‑2028 and use of proceeds plus revolver/cash to repay the $200 million March‑2026 notes, leaving gross leverage of 1.33x and net leverage of 1.20x. Portfolio and operating metrics cited: $508 million of new debt commitments in 2025, $287 million funded in 2025 (vs. $135m prior year), Q4 fundings of $93m to 16 companies (onboarding yield ~12%), full‑year weighted average portfolio yield 13.7% (Q4 12.7%; core excl. prepayments 12.1%), investment portfolio fair value ~$784m (+16% y/y), NAV $8.73/share (vs. $8.61), net investment income $42.3m or $1.05/share for FY2025, distributions paid $1.08/share, spillover income ~$42.3m or $1.04/share, ~63% of debt portfolio floating with ~79% of those at prime floors (limiting downside from further rate cuts), and the adviser’s income incentive fee waiver extended through 2026 while the sponsor purchased ~2.0 million shares (~5% of outstanding).

TriplePoint Venture Growth Financial Statement Overview

Summary
Revenue growth improved in 2024–2025, and leverage metrics appear better, but results are erratic: large losses in 2022–2023, a sharp profitability rebound in 2024, then 2025 shows zero reported profit despite higher revenue. Cash flow also swung from strong positive in 2023–2024 to negative in 2025, raising durability concerns.
Income Statement
46
Neutral
Revenue rebounded strongly in 2024 (+10.9%) and accelerated further in 2025 (+36.9%), but profitability is highly volatile. After large losses in 2022–2023 (deeply negative margins), 2024 showed a sharp recovery with strong net profitability (~45% net margin). However, 2025 reports zero profit and zero margins despite higher revenue, which raises questions about earnings quality/consistency and makes the trend less dependable.
Balance Sheet
58
Neutral
Leverage improved materially: debt-to-equity moved down from 1.76x (2023) to 1.15x (2024), and 2025 shows no reported debt with equity up to ~$354M (supportive for solvency if accurate). That said, the company has historically operated with meaningful leverage and returns on equity have swung from negative (2022–2023) to positive (2024) and then back to zero in 2025, highlighting uneven underlying performance.
Cash Flow
41
Neutral
Cash generation is inconsistent. Operating and free cash flow were strong and positive in 2023–2024 (including a large ~$153M in 2024), but flipped sharply negative in 2025 to about -$57M, with a steep free-cash-flow decline versus the prior year. Earlier years also show sizable cash burn (2021–2022), so overall cash-flow stability remains a key risk.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue97.21M71.19M5.97M13.39M100.74M
Gross Profit81.18M45.53M-27.07M-9.51M87.35M
EBITDA75.73M32.05M-39.82M-20.07M76.56M
Net Income49.21M32.05M-39.82M-20.07M76.56M
Balance Sheet
Total Assets839.65M763.04M978.83M1.01B927.67M
Cash, Cash Equivalents and Short-Term Investments20.36M45.90M153.33M51.49M51.27M
Total Debt469.08M398.83M607.90M566.98M467.50M
Total Liabilities486.03M417.35M632.52M594.59M493.18M
Stockholders Equity353.62M345.69M346.31M419.94M434.49M
Cash Flow
Free Cash Flow-57.03M152.92M49.23M-100.89M-144.68M
Operating Cash Flow-57.03M152.92M49.23M-100.89M-144.68M
Investing Cash Flow-77.11M0.0056.92M-421.00M-417.37M
Financing Cash Flow25.67M-245.78M6.17M101.00M159.15M

TriplePoint Venture Growth Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.25
Price Trends
50DMA
5.97
Negative
100DMA
5.92
Negative
200DMA
6.02
Negative
Market Momentum
MACD
-0.20
Negative
RSI
35.72
Neutral
STOCH
33.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TPVG, the sentiment is Negative. The current price of 5.25 is below the 20-day moving average (MA) of 5.46, below the 50-day MA of 5.97, and below the 200-day MA of 6.02, indicating a bearish trend. The MACD of -0.20 indicates Negative momentum. The RSI at 35.72 is Neutral, neither overbought nor oversold. The STOCH value of 33.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TPVG.

TriplePoint Venture Growth Risk Analysis

TriplePoint Venture Growth disclosed 87 risk factors in its most recent earnings report. TriplePoint Venture Growth reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

TriplePoint Venture Growth Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
66
Neutral
$1.23B7.4914.09%13.53%33.44%25.22%
64
Neutral
$227.75M6.7810.94%13.03%315.14%116.85%
62
Neutral
$257.97M35.45%5.39%
59
Neutral
$311.46M10.645.42%16.61%-3.09%200.66%
52
Neutral
$212.58M5.3514.02%17.28%206.13%298.86%
50
Neutral
$274.13M0.03%12.83%90.34%-44.25%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TPVG
TriplePoint Venture Growth
5.25
-1.04
-16.53%
SSSS
SuRo Capital
10.27
5.00
94.80%
PNNT
Pennantpark Investment
4.77
-1.20
-20.03%
SCM
Stellus Capital
9.47
-2.73
-22.38%
TRIN
Trinity Capital
14.80
1.51
11.36%
LIEN
Chicago Atlantic BDC
9.98
-0.42
-4.04%

TriplePoint Venture Growth Corporate Events

Business Operations and StrategyDividendsFinancial DisclosuresPrivate Placements and Financing
TriplePoint Venture Growth Reports Strong 2025 Investment Income
Positive
Mar 4, 2026

TriplePoint Venture Growth BDC Corp. reported on March 4, 2026 that it achieved net investment income of $42.3 million, or $1.05 per share, for fiscal 2025 and a net increase in net assets from operations of $1.22 per share, supported by strong portfolio yields and expanded originations. Over 2025, the firm grew its investment portfolio to $783.5 million, increased the number of debt portfolio companies to 55, modestly lifted net asset value to $8.73 per share, and paid $1.08 per share in total dividends, while securing an extended and cheaper revolving credit facility, maintaining an investment-grade rating, and refinancing upcoming unsecured debt with new investment-grade notes, steps that collectively strengthen its balance sheet and position it for continued growth in venture lending.

The most recent analyst rating on (TPVG) stock is a Buy with a $6.50 price target. To see the full list of analyst forecasts on TriplePoint Venture Growth stock, see the TPVG Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
TriplePoint Venture Growth Refinances 2026 Notes, Enhancing Flexibility
Positive
Mar 2, 2026

On February 27, 2026, TriplePoint Venture Growth BDC Corp. entered into a $75 million master note purchase agreement for senior unsecured notes due February 27, 2028, carrying a fixed annual interest rate of 7.50% and sold in a private placement to a qualified institutional investor. The notes, which rank pari passu with the company’s other unsecured unsubordinated debt, feature quarterly interest payments, optional redemption provisions, change-of-control prepayment rights, and interest step-ups tied to credit rating and secured debt metrics.

On March 2, 2026, the company applied the proceeds from the new Series 2026 notes, together with borrowings from its revolving credit facility and cash on hand, to fully repay at maturity its $200 million 4.50% unsecured notes due March 2026, including accrued interest. The associated covenants, including a minimum asset coverage ratio and minimum stockholders’ equity thresholds, reinforce balance sheet discipline and regulatory status requirements, underscoring TriplePoint’s efforts to actively manage its liability profile and maintain financial flexibility in a higher-rate environment.

The most recent analyst rating on (TPVG) stock is a Buy with a $6.50 price target. To see the full list of analyst forecasts on TriplePoint Venture Growth stock, see the TPVG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 05, 2026